VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Amgen Inc. vs Heineken N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Heineken N.V.
HEIA · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Heineken N.V.'s moat claims, evidence, and risks.
View HEIA analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 65 / 100 for Heineken N.V.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Heineken N.V. has 4 segments (38.7% in Europe).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Heineken N.V. has 5 across 2.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Heineken N.V.
Europe
Beer, cider and beyond-beer alcoholic beverages
Europe
Consumers via on-trade (bars/restaurants) and off-trade (retail/wholesale)
Brewer / brand owner / route-to-market operator
38.7%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Heineken N.V. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Heineken N.V. segments
Full profile >Europe
Oligopoly
Americas
Oligopoly
Africa & Middle East
Oligopoly
Asia Pacific
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.